Neurosoft Bioelectronics

company

About

Neurosoft Bioelectronics is developing next-generation soft implantable electrodes to interface with the nervous system.

  • 1 - 10

Details

Last Funding Type
Grant
Last Funding Money Raised
Fr2.55M
Industries
Health Care,Medical,Medical Device,Neuroscience
Founded date
Feb 1, 2019
Number Of Employee
1 - 10
Operating Status
Active

Neurosoft Bioelectronics is developing next-generation soft implantable electrodes to interface with the nervous system. Neural implants are medical devices made of electrodes that can record or stimulate the brain, spinal cord, or peripheral nerves to monitor or treat patients suffering from neurological disorders. However, current clinical devices are too stiff compared to the soft tissues of the body, which limits benefits for patients. At Neurosoft Bioelectronics, we have developed a new generation of soft and conformable implantable electrodes that seamlessly interface with the nervous tissues and can improve clinical outcomes for patients.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
Fr2.55M
Neurosoft Bioelectronics has raised a total of Fr2.55M in funding over 2 rounds. Their latest funding was raised on Mar 29, 2022 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 29, 2022 Grant Fr2.55M 1 European Innovation Council Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Neurosoft Bioelectronics is funded by 1 investors. European Innovation Council are the most recent investors.
Investor Name Lead Investor Funding Round
European Innovation Council Yes Grant